Company news: Zelira Therapeutics; Ecofibre; Cann Group; InhaleRx; Argent Biopharma; Melodiol Global Health; Wellnex Life by Steve Jones July 4, 2024July 4, 2024 Shares in Zelira Therapeutics jumped 9% in Monday morning trading after its chairman, Osagie Imasogie, agreed […]
Wellnex shelves low dose S3 move amid ‘remote’ chance of registration by Steve Jones June 11, 2024June 11, 2024
Wellnex to launch range of cannabis medicine as more products enter market by Steve Jones June 5, 2024June 6, 2024
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Cann Compounding; Ecofibre; Ora Pharm; Althea; Melodiol Global Health; Wellnex Life; Emyria by Martin Lane and Steve Jones April 24, 2024April 24, 2024
Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024February 7, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health by Martin Lane November 14, 2023April 30, 2024
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023